Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-13-013142)

Filing Details

Accession Number:: 0001127602-13-013142
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2013-04-03 12:31:15
Reporting Period:: 2013-04-01

Filing Date:: 2013-04-03
Accepted Time:: 2013-04-03 12:31:15
Original Submission Date:: 2013-04-02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875045	Biogen Idec Inc.	BIIB	Biological Products, (No Disgnostic Substances) (2836)	330112644

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1202102	A George Scangos	Biogen Idec Inc. 133 Boston Post Road Weston MA 02493	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-04-01	1,598	$193.66	52,107	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,378	Indirect	by Trust
Common Stock	5,378	Indirect	by Trust

Footnotes

Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
This amendment is being filed solely to file the power of attorney as an exhibit. No changes have been made to the transactions reported by the reporting person in his Form 4 filed with the SEC on April 2, 2013.